Ileal bile acid transporter inhibitors in Alagille syndrome and Progressive Familial Intrahepatic Cholestasis: A systematic review into dose–response

Documenti analoghi

• Bleeding in patients on concurrent treatment with a selective serotonin reuptake inhibitor (SSRI) and low‐dose acetylsalicylic acid (ASA) compared with SSRI or low‐dose ASA alone—A systematic review and meta‐analysis
  di: Magnus A. B. Axelsson, et al.
  Pubblicazione: (2024)
• Influence of gut bile acid composition on the glucose‐lowering effect and safety of metformin
  di: Deok Yong Yoon, et al.
  Pubblicazione: (2024)
• Altered bile acid and coproporphyrin‐I disposition in patients with autosomal dominant polycystic kidney disease
  di: Jacqueline B. Tiley, et al.
  Pubblicazione: (2024)
• Cholinergic G protein‐coupled bile acid receptor 1 (TGR5/GPBA) in the medial septal orchestrates adult hippocampal neurogenesis and cognition in Alzheimer's disease mice
  di: Rui‐Zhe Nie, et al.
  Pubblicazione: (2025)
• Resveratrol, a novel inhibitor of fatty acid binding protein 5, inhibits cervical cancer metastasis by suppressing fatty acid transport into nucleus and downstream pathways
  di: Xiao Chen, et al.
  Pubblicazione: (2024)